Menu

City Therapeutics, Inc. CTY

Full chart Compare
Set alert

Price alert · CTY

All alert types
18.25 USD +1.18 (+6.91%)

At closeNov 6, 2026, 4:00 PM EST

18.25 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

17.49 Day range 18.56
16.41 52-week range 22.40
YTD
-18.53%
1 year
-18.53%

Revenue & Expenses

Other Income → Expenses: $3.67MExpenses → Selling, General & Admin: $15.06MExpenses → Research & Development: $58.42MExpenses → Interest Expense: $2.26MGross Profit → Expenses: $13.56MRevenue → Gross Profit: $13.56MNet Loss → Expenses: $58.51MOther Income$3.67MGross Profit$13.56MNet Loss$58.51MExpenses$75.74MSelling, General & Admin$15.06MResearch & Development$58.42MInterest Expense$2.26MRevenue$13.56M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CTY annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
13.56M2.78M
13.56M2.78M
-59.92M-29.09M
-58.51M-27.84M
-12.46-8.18
CTY annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
115.30M128.43M
149.77M145.35M
89.91M30.26M
67.28M22.30M
-84.66M-29.43M
CTY annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-41.61M-20.39M
-2.38M-3.38M
30.86M149.44M
-2.38M-3.38M
-13.13M125.67M